Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease

We aimed to evaluate whether adding a sustained-release (SR) formula of mosapride to proton-pump inhibitors (PPIs) would be more effective in controlling symptoms than PPI alone in patients with gastroesophageal reflux disease (GERD). Sixty patients with heartburn and/or regurgitation were randomly...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Hye Kyung, Kim, Gwang Ha, Lee, Moon Won, Joo, Dong Chan, Lee, Bong Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999938/
https://www.ncbi.nlm.nih.gov/pubmed/35407572
http://dx.doi.org/10.3390/jcm11071965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999938/
https://www.ncbi.nlm.nih.gov/pubmed/35407572
http://dx.doi.org/10.3390/jcm11071965

Ejemplares similares